MCOPS6
MCOPS6 Chemical Properties
- storage temp.
- -20°C
- form
- buffered aqueous glycerol solution
- biological source
- rabbit
MCOPS6 Usage And Synthesis
Uses
Suggested starting dilutions are as follows: ICC/IF: 1:100-1:1000, IHC-P: 1:100-1:1000, WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.
Biological Activity
The protein encoded by this gene is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. This particular family member plays an important role in the onset of endochondral bone formation in humans, and a reduction in expression has been associated with a variety of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Alternative splicing in the 5μ untranslated region of this gene has been described and three variants are described, all encoding an identical protein. [provided by RefSeq]
IC 50
IL-6; COX-2
Description
Bone Morphogenetic Protein-4 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 116 amino acids and having a molecular mass of 13kDa.
The BMP-4 is purified by proprietary chromatographic techniques.
Source
Escherichia Coli
Background
The protein encoded by this gene is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. This particular family member plays an important role in the onset of endochondral bone formation in humans, and a reduction in expression has been associated with a variety of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Alternative splicing in the 5' untranslated region of this gene has been described and three variants are described, all encoding an identical protein.
MCOPS6Supplier
- Tel
- 13758194781 13173652190
- 522013271@qq.com
- Tel
- 021-34661275 15301693058
- yajikit@163.com
- Tel
- 021-59178156 17002132182
- 3146474380@qq.com
- Tel
- 021-60345367 13916550749
- sales@shzbio.com
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com